This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TCR (Bellicum)

Bellicum Pharmaceuticals, Inc.

Drug Names(s): TCR (Bellicum)

Description: Bellicum Pharmaceuticals is developing high-affinity TCR (T cell receptor) product candidates with Leiden University Medical Center (LUMC).

TCR (Bellicum) News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug